Cargando…

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer

One of the challenges for Latin American countries is to include in their healthcare systems technologies that can be applied to hereditary cancer detection and management. The aim of the study is to create and validate a questionnaire to identify individuals with possible risk for hereditary cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Campacci, Natalia, de Lima, Juliana O., Carvalho, André L., Michelli, Rodrigo D., Haikel, Rafael, Mauad, Edmundo, Viana, Danilo V., Melendez, Matias E., Vazquez, Fabiana de L., Zanardo, Cleyton, Reis, Rui M., Rossi, Benedito M., Palmero, Edenir I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727305/
https://www.ncbi.nlm.nih.gov/pubmed/29055968
http://dx.doi.org/10.1002/cam4.1210
_version_ 1783285853563387904
author Campacci, Natalia
de Lima, Juliana O.
Carvalho, André L.
Michelli, Rodrigo D.
Haikel, Rafael
Mauad, Edmundo
Viana, Danilo V.
Melendez, Matias E.
Vazquez, Fabiana de L.
Zanardo, Cleyton
Reis, Rui M.
Rossi, Benedito M.
Palmero, Edenir I.
author_facet Campacci, Natalia
de Lima, Juliana O.
Carvalho, André L.
Michelli, Rodrigo D.
Haikel, Rafael
Mauad, Edmundo
Viana, Danilo V.
Melendez, Matias E.
Vazquez, Fabiana de L.
Zanardo, Cleyton
Reis, Rui M.
Rossi, Benedito M.
Palmero, Edenir I.
author_sort Campacci, Natalia
collection PubMed
description One of the challenges for Latin American countries is to include in their healthcare systems technologies that can be applied to hereditary cancer detection and management. The aim of the study is to create and validate a questionnaire to identify individuals with possible risk for hereditary cancer predisposition syndromes (HCPS), using different strategies in a Cancer Prevention Service in Brazil. The primary screening questionnaire (PSQ) was developed to identify families at‐risk for HCPS. The PSQ was validated using discrimination measures, and the reproducibility was estimated through kappa coefficient. Patients with at least one affirmative answer had the pedigree drawn using three alternative interview approaches: in‐person, by telephone, or letter. Validation of these approaches was done. Kappa and intraclass correlation coefficients were used to analyze data's reproducibility considering the presence of clinical criteria for HCPS. The PSQ was applied to a convenience sample of 20,000 women of which 3121 (15.6%) answered at least one affirmative question and 1938 had their pedigrees drawn. The PSQ showed sensitivity and specificity scores of 94.4% and 75%, respectively, and a kappa of 0.64. The strategies for pedigree drawing had reproducibility coefficients of 0.976 and 0.850 for the telephone and letter approaches, respectively. Pedigree analysis allowed us to identify 465 individuals (24.0%) fulfilling at least one clinical criterion for HCPS. The PSQ fulfills its function, allowing the identification of HCPS at‐risk families. The use of alternative screening methods may reduce the number of excluded at‐risk individuals/families who live in locations where oncogenetic services are not established.
format Online
Article
Text
id pubmed-5727305
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57273052017-12-13 Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer Campacci, Natalia de Lima, Juliana O. Carvalho, André L. Michelli, Rodrigo D. Haikel, Rafael Mauad, Edmundo Viana, Danilo V. Melendez, Matias E. Vazquez, Fabiana de L. Zanardo, Cleyton Reis, Rui M. Rossi, Benedito M. Palmero, Edenir I. Cancer Med Cancer Prevention One of the challenges for Latin American countries is to include in their healthcare systems technologies that can be applied to hereditary cancer detection and management. The aim of the study is to create and validate a questionnaire to identify individuals with possible risk for hereditary cancer predisposition syndromes (HCPS), using different strategies in a Cancer Prevention Service in Brazil. The primary screening questionnaire (PSQ) was developed to identify families at‐risk for HCPS. The PSQ was validated using discrimination measures, and the reproducibility was estimated through kappa coefficient. Patients with at least one affirmative answer had the pedigree drawn using three alternative interview approaches: in‐person, by telephone, or letter. Validation of these approaches was done. Kappa and intraclass correlation coefficients were used to analyze data's reproducibility considering the presence of clinical criteria for HCPS. The PSQ was applied to a convenience sample of 20,000 women of which 3121 (15.6%) answered at least one affirmative question and 1938 had their pedigrees drawn. The PSQ showed sensitivity and specificity scores of 94.4% and 75%, respectively, and a kappa of 0.64. The strategies for pedigree drawing had reproducibility coefficients of 0.976 and 0.850 for the telephone and letter approaches, respectively. Pedigree analysis allowed us to identify 465 individuals (24.0%) fulfilling at least one clinical criterion for HCPS. The PSQ fulfills its function, allowing the identification of HCPS at‐risk families. The use of alternative screening methods may reduce the number of excluded at‐risk individuals/families who live in locations where oncogenetic services are not established. John Wiley and Sons Inc. 2017-10-21 /pmc/articles/PMC5727305/ /pubmed/29055968 http://dx.doi.org/10.1002/cam4.1210 Text en © 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Campacci, Natalia
de Lima, Juliana O.
Carvalho, André L.
Michelli, Rodrigo D.
Haikel, Rafael
Mauad, Edmundo
Viana, Danilo V.
Melendez, Matias E.
Vazquez, Fabiana de L.
Zanardo, Cleyton
Reis, Rui M.
Rossi, Benedito M.
Palmero, Edenir I.
Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
title Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
title_full Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
title_fullStr Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
title_full_unstemmed Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
title_short Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
title_sort identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727305/
https://www.ncbi.nlm.nih.gov/pubmed/29055968
http://dx.doi.org/10.1002/cam4.1210
work_keys_str_mv AT campaccinatalia identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT delimajulianao identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT carvalhoandrel identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT michellirodrigod identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT haikelrafael identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT mauadedmundo identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT vianadanilov identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT melendezmatiase identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT vazquezfabianadel identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT zanardocleyton identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT reisruim identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT rossibeneditom identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer
AT palmeroedeniri identificationofhereditarycancerinthegeneralpopulationdevelopmentandvalidationofascreeningquestionnaireforobtainingthefamilyhistoryofcancer